SEC Form 4 · accession 0001804831-26-000005
ICU MEDICAL INC/DE · ICUI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Michael Bonnell
Officer — Chief Financial Officer
Period of report
Aug 31, 2026
Accepted (ET)
Aug 31, 2026 · 4:43 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000883984
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 31, 2026 | S | 1,712 | $171.0532 | D | 70,038 | D | |
| Common StockF1,F3 | Aug 31, 2026 | S | 1,914 | $172.1226 | D | 68,124 | D | |
| Common StockF1,F4 | Aug 31, 2026 | S | 4,568 | $173.4437 | D | 63,556 | D | |
| Common StockF1,F5 | Aug 31, 2026 | S | 1,113 | $173.9144 | D | 62,443 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.57 to $171.495, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.625 to $172.6, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.69 to $173.765, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.77 to $174.08, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.